PDT Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,905
| Closed | -$281K | – | 945 |
|
|
2021
Q2 | $281K | Buy |
3,905
+628
| +19% | +$45.2K | 0.02% | 625 |
|
|
2021
Q1 | $242K | Buy |
+3,277
| New | +$242K | 0.02% | 660 |
|
|
2020
Q4 | – | Sell |
-4,800
| Closed | -$263K | – | 882 |
|
|
2020
Q3 | $263K | Sell |
4,800
-1,300
| -21% | -$71.2K | 0.02% | 570 |
|
|
2020
Q2 | $406K | Sell |
6,100
-2,000
| -25% | -$133K | 0.03% | 463 |
|
|
2020
Q1 | $496K | Hold |
8,100
| – | – | 0.04% | 373 |
|
|
2019
Q4 | $712K | Buy |
+8,100
| New | +$712K | 0.04% | 345 |
|
|
2015
Q3 | – | Sell |
-18,512
| Closed | -$2.66M | – | 1629 |
|
|
2015
Q2 | $2.66M | Buy |
18,512
+772
| +4% | +$111K | 0.07% | 336 |
|
|
2015
Q1 | $2.5M | Buy |
17,740
+11,240
| +173% | +$1.59M | 0.06% | 388 |
|
|
2014
Q4 | $963K | Buy |
6,500
+1,200
| +23% | +$178K | 0.09% | 308 |
|
|
2014
Q3 | $815K | Buy |
5,300
+1,000
| +23% | +$154K | 0.02% | 769 |
|
|
2014
Q2 | $603K | Sell |
4,300
-1,129
| -21% | -$158K | 0.02% | 886 |
|
|
2014
Q1 | $603K | Buy |
5,429
+2,040
| +60% | +$227K | 0.01% | 854 |
|
|
2013
Q4 | $335K | Buy |
3,389
+94
| +3% | +$9.29K | 0.04% | 511 |
|
|
2013
Q3 | $250K | Sell |
3,295
-3,169
| -49% | -$240K | 0.01% | 1324 |
|
|
2013
Q2 | $361K | Buy |
+6,464
| New | +$361K | 0.01% | 1199 |
|